Abstract
Recent advances in the understanding of human behaviors indicate that genetic factors often play a critical role in regulating variation in behavior. Special attention has been paid to abnormal behaviors ranging from psychopathology to drug, usually alcohol, dependence. This chapter summarizes the data that suggest that genetic factors regulate the nicotinic and muscarinic cholinergic systems. Studies that indicate that the use of tobacco products by humans is genetically regulated are discussed in detail, as are animal studies that indicate that genetically determined differences in several aspects of nicotine pharmacology exist. Special emphasis is placed on those animal studies that have identified biochemical processes that may play critical roles in regulating genetically influenced variation in nicotine’s actions. A more cursory discussion of the genetics of human affective disorders is followed by an equally cursory summation of the limited animal literature, which argues that genetically determined variation in muscarinic cholinergic systems exists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anisman, H., and Cygan, D., 1975, Central effects of scopolamine and (+)amphetamine on locomotor activity: Interaction with strain and stress variables, Neuropharmacology 14:835–840.
Ayers, J., Ruff, C. F., and Templer, D. I., 1976, Alcoholism, cigarette smoking, coffee drinking and extraversion, J. Stud. Alcohol 37:983–985.
Balfour, D. J. K., 1980, Studies on the biochemical and behavioral effects of oral nicotine, Arch. Int. Pharmacodyn. 245:95–103.
Battig, K., Driscoll, P., Schlatter, J., and Uster, H. J., 1976, Effects of nicotine on the exploratory locomotion patterns of female Roman high and low avoidance rats, Pharmacol. Biochem. Behav. 4:435–439.
Bennet, E. L., Rosenzweig, M. R., Kreech, D., Karlsson, H., Dyne, N., and Ohlander, A., 1958, Individual, strain and age differences in cholinesterase activity of the rat brain, J. Neurochem. 3:144–152.
Bignami, G., 1965, Selection for high rates and low rates of avoidance conditioning in the rat, Anim. Behav. 13:221–227.
Bovet, D., Bovet-Nitti, F., and Oliverio, A., 1967, Action of nicotine on spontaneous and acquired behavior in rats and mice, Ann. N. Y. Acad. Sci. 142:261–267.
Brimblecombe, R. W., Buxton, D. A., and Redfern, P. H., 1975, Drug effects on avoidance behaviour in selected strains of rats, Br. J. Pharmacol. 53:461P.
Broadhurst, P. L., 1960, Experiments in psychogenetics: Applications of biometrical genetics to the inheritance of behaviour, in: Experiments in Personality, Volume I, Psychogenetics and Psychopharmacology, (H. J. Eysenck, ed.) Routledge and Kegan Paul, London, pp. 1–102.
Broadhurst, P. L., 1962, A note on further progress in a psychogenetic selection experiment, Psychol. Rep. 10:65–66.
Buxton, D. A., Brimblecombe, R. W., French, M. C., and Redfern, P. H., 1976, Brain acetylcholine concentration and acetylcholinesterase activity in selectively-bred strains of rats, Psychopharmacology 47:97–99.
Cederlof, R., Friberg, L., and Lundman, T., 1977, The interactions of smoking, environment and heredity and their implications for disease etiology, Acta Med. Scand. [Suppl.] 612:2–127.
Collins, A. C., and Marks, M. J., 1989, Chronic nicotine exposure and brain nicotinic receptors — influence of genetic factors, Prog. Brain Res. 79:137–146.
Conterio, F., and Chiarelli, B., 1962, Study of the inheritance of some daily habits, Heredity 17:347–359.
Crumpacker, D. W., Cederlof, R., Friberg, L., Kimberling, W. J., Sorensen, S., Vandenberg, S. G., Williams, J. S., McClearn, G. E., Grever, B., Lyer, H., Krier, M. J., Pedersen, N. L., Price, R. A., and Roulette, I., 1979, A twin methodology for the study of genetic and environmental control of variation in human smoking behavior, Acta Genet. Med. Gemellol. 28:173–195.
de Fiebre, C. M., and Collins, A. C., 1988, Decreased sensitivity to nicotine-induced seizures as a consequence of nicotine pretreatment in long-sleep and short sleep-mice, Alcohol 5:55–61.
de Fiebre, C. M., and Collins, A. C., 1989, Behavioral desensitization to nicotine is enhanced differentially by ethanol in long-sleep and short-sleep mice, Alcohol 6:45–51.
de Fiebre, C. M., Medhurst, L. J., and Collins, A. C., 1987, Nicotine response and nicotinic receptors in long-sleep and short-sleep mice, Alcohol 4:493–501.
Dies, R., Honeyman, M., Reznikoff, M., and White, C., 1969, Personality and smoking patterns in a twin population, J. Pro. Tech. Pers. Assess. 33:457–463.
Durcan, M. J., Garcha, H. S., and Stolerman, I. P., 1988, Conditioned taste aversions produced by nicotine in Roman High and Low Avoidance strains of rats, Psychopharmacology 94:532–535.
Eysenck, H. J., 1980, The Causes and Effects of Smoking, Tempie Smith, London.
Fisher, R. A., 1958a, Lung cancer and cigarettes? Nature 182:108.
Fisher, R. A., 1958b, Cancer and smoking, Nature 182:596.
Fleming, J. C., and Broadhurst, P. L., 1975, The effects of nicotine on two-way avoidance conditioning in bi-directionally selected strains of rats, Psychopharmacologia 42:147–152.
Freund, R. K., Martin, B. J., Jungschaffer, D. A., Ullman, E. A., and Collins, A. C., 1988, Genetic differences in plasma corticosterone levels in response to nicotine injection, Pharmacol. Biochem. Behav. 30:1059–1064.
Friberg, L., Kaij, L., and Dencker, S. J., 1959, Smoking habits of monozygotic and dizygotic twins, Br. Med. J. 1:1090–1092.
Friedman, G. D., King, M., Klatsky, A. L., and Hulley, S. B., 1981, Characteristics of smoking-discordant monozygotic twins, in: Twin Research 3: Epidemiological and Clinical Studies (L. Gedda, P. Parisi, and W. G. Nance, eds.), Alan R. Liss, New York, pp. 17–22.
Garg, M., 1968, The effect of nicotine on rearing in two strains of rats, Life Sci. 7:421–429.
Garg, M., 1969a, The effects of some central nervous system stimulant and depressant drugs on rearing activity in rats, Psychopharmacologia 14:150–156.
Garg, M., 1969b, Variation in effects of nicotine in four strains of rats, Psychopharmacologia 14:432–438.
Garg, M., 1969c, The effect of nicotine on two different types of learning, Psychopharmacologia 15:408–414.
Garg, M., and Holland, H. C., 1969, Consolidation and maze learning: A study of some strain/drug interactions, Psychopharmacologia 14:426–431.
Gershon, E. S., 1983, Genetics of the major psychoses, in: Genetics of Neurological and Psychiatric Disorders (S. S. Kety, L. P. Rowland, R. L. Sidman, and S. W. Matthysse, eds.), Raven Press, New York, pp. 60–124.
Goldberg, S. R., and Henningfield, J. E., 1988, Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of IV drug injection, Pharmacol. Biochem. Behav. 30:227–234.
Griffiths, R. R., Bigelow, G. E., and Liebson, I., 1976, Facilitation of human tobacco self-administration by ethanol: A behavioral analysis, J. Exp. Anal. Behav. 25:279–292.
Gurling, H. M. D., Grant, S., and Dangl, J., 1985, The genetic and cultural transmission of alcohol use, alcoholism, cigarette smoking and coffee drinking: A review and an example using a log linear cultural transmission model, Br. J. Addict. 80:269–279.
Hatchell, P. C., and Collins, A. C., 1977, Influences of genotype and sex on behavioral tolerance to nicotine in mice, Pharmacol. Biochem. Behav. 6:25–30.
Hatchell, P. C., and Collins, A. C., 1980, The influence of genotype and sex on behavioral sensitivity to nicotine in mice, Psychopharmacology 71:45–49.
Hatsukami, D. K., Hughes, J. R., Pickens, R. W., and Svikis, D., 1984, Tobacco withdrawal symptoms: An experimental analysis, Psychopharmacology 84:231–236.
Hatsukami, D. K., Hughes, J. R., and Pickens, R. W., 1985, Blood nicotine, smoke exposure and tobacco withdrawal symptoms, Addict. Behav. 10:413–417.
Henningfield, J. E., 1984, Behavioral pharmacology of cigarette smoking, in: Advances in Behavioral Pharmacology (T. Thompson and P. B. Dews, eds.), Academic Press, New York, Vol. IV, pp. 131–210.
Henningfield, J. E., Chait, L. D., and Griffiths, R. R., 1983, Cigarette smoking and subjective response in alcoholics: Effects of pentobarbital, Clin. Pharmacol. Ther. 31:806–812.
Hodgkinson, S., Mullan, M. J., and Gurling, H. M. D., 1990, The role of genetic factors in the etiology of the affective disorders, Behav. Genet. 20:235–250.
Janowsky, D. S., Risch, S. C., Judd, L. L., Leighton, Y. H., and Parker, D. C., 1985, Brain cholinergic systems and the pathogenesis of affective disorders, in: Central Cholinergic Mechanisms and Adaptive Dysfunctions (M. M. Singh, D. M. Warburton, and L. Harbans, eds.), New York, Plenum Press, pp. 309–333.
Jones, R. A., 1986, Individual differences in nicotine sensitivity, Addict. Behav. 11:435–438.
Kaprio, J., Koskenvuo, M., and Sarna, S., 1981, Cigarette smoking, use of alcohol, and leisure-time physical activity among same-sexed adult male twins, in: Twin Research 3: Epidemiological and Clinical Studies (L. Gedda, P. Parisi and W. E. Nance, eds.), Alan R. Liss, New York, pp. 37–46.
Kozlowski, L. T., and Herman, C. P., 1984, The interaction of psychosocial and biological determinants of tobacco use: More on the boundary model, J. Appl. Soc. Psychol. 14:244–256.
Lush, I. E., and Andrews, K. M., 1978, Genetical differences in sensitivity to tremorine and oxotremorine in mice, Eur. J. Pharmacol. 49:95–103.
Marks, M. J., and Collins, A. C., 1982, Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate, Mol. Pharmacol. 22:554–564.
Marks, M. J., Patinkin, D. M., Artman, L. D., Burch, J. B., and Collins, A. C., 1981, Genetic influences on cholinergic drug response, Pharmacol. Biochem. Behav. 15:271–279.
Marks, M. J., Burch, J. B., and Collins, A. C., 1983a, Genetics of nicotine response in four inbred strains of mice, J. Pharmacol. Exp. Ther. 226:291–302.
Marks, M. J., Burch, J. B., and Collins, A. C., 1983b, Effects of chronic nicotine infusion on tolerance development and cholinergic receptors, J. Pharmacol. Exp. Ther. 226:806–816.
Marks, M. J., Miner, L., Burch, J. B., Fulker, D. W., and Collins, A. C., 1984, A diallel analysis of nicotine-induced hypothermia, Pharmacol. Biochem. Behav. 21:953–959.
Marks, M. J., Romm, E., Bealer, S. M., and Collins, A. C., 1985a, A test battery for measuring nicotine effects in mice, Pharmacol. Biochem. Behav. 23:325–330.
Marks, M. J., Stitzel, J. A., and Collins, A. C., 1985b, Time course study of the effects of chronic nicotine infusion on drug response and brain receptors, J. Pharmacol. Exp. Ther. 235:619–628.
Marks, M. J., Miner, L. L., Cole-Harding, S., Burch, J. B., and Collins, A. C., 1986a, A genetic analysis of nicotine effects on open field activity, Pharmacol. Biochem. Behav. 24:743–749.
Marks, M. J., Romm, E., Gaffney, D. K., and Collins, A. C., 1986b, Nicotine-induced tolerance and receptor changes in four mouse strains, J. Pharmacol. Exp. Ther. 237:809–819.
Marks, M. J., Stitzel, J. A., and Collins, A. C., 1986c, Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains, J. Pharmacol. Exp. Ther. 239:358–364.
Marks, M. J., Romm, E., and Collins, A. C., 1987, Genetic influences on tolerance development with chronic oxotremorine infusion, Pharmacol. Biochem. Behav. 27:723–732.
Marks, M. J., Stitzel, J. A., and Collins, A. C., 1989a, Genetic influences on nicotine responses, Pharmacol. Biochem. Behav. 33:667–678.
Marks, M. J., Romm, E., Campbell, S. M., and Collins, A. C., 1989b, Variation of nicotinic binding sites among inbred strains, Pharmacol. Biochem. Behav. 33:679–689.
Martin, B. J., and Wehner, J. M., 1988, Influence of genotype on nicotine-induced increases of plasma corticosterone in mice as a result of acute nicotine pretreatment, Pharmacol. Biochem. Behav. 30:1065–1070.
Martin, J. R., Overstreet, D. H., Driscoll, P., and Battig, K., 1981, Effects of scopolamine, pilocarpine, and oxotremorine on the exploratory behavior of two psychogenetically selected lines of rats in a complex maze, Psychopharmacology 72:135–142.
Martin, J. R., Driscoll, P., and Gentsch, C., 1984, Differential response to cholinergic stimulation in psychogenetically selected rat lines, Psychopharmacology 83:262–267.
McClearn, G. E., and Kakihana, R., 1973, Selective breeding for ethanol sensitivity in mice, Behav. Genet. 3:409–410.
Miner, L. L., and Collins, A. C., 1988a, Effect of nicotine pretreatment on nicotine-induced seizures, Pharmacol. Biochem. Behav. 29:375–380.
Miner, L. L., and Collins, A. C., 1988b, The effect of chronic nicotine treatment on nicotine-induced seizures, Psychopharmacology 95:52–55.
Miner, L. L., and Collins, A. C., 1989, Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors, Pharmacol. Biochem. Behav. 33:469–475.
Miner, L. L., Marks, M. J., and Collins, A. C., 1984, Classical genetic analysis of nicotine-induced seizures and nicotinic receptors, J. Pharmacol. Exp. Ther. 231:545–554.
Miner, L. L., Marks, M. J., and Collins, A. C., 1985, Relationship between nicotine-induced seizures and hippocampal nicotinic receptors, Life Sci. 37:75–83.
Miner, L. L., Marks, M. J., and Collins, A. C., 1986, Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse, J. Pharmacol. Exp. Ther. 239:853–860.
Morrison, C. F., and Lee, P. N., 1968, A comparison of the effects of nicotine and physostigmine on a measure of activity in the rat, Psychopharmacologia 13:210–221.
Oliverio, A., Eleftheriou, B. E., and Bailey, D. W., 1973, Exploratory activity: Genetic analysis of its modification by scopolamine and amphetamine, Physiol. Behav. 10:893–899.
Omenn, G. S., and Motulsky, A. G., 1972, A biochemical and genetic approach to alcoholism, Ann. N.Y. Acad. Sci. 197:16–23.
O’Rourke, D. H., McGuffin, P., and Reich, T., 1983, Genetic analysis of manic-depressive illness, Am. J. Phys. Anthropol. 62:51–59.
Overstreet, D. H., 1986, Selective breeding for increased cholinergic function: Development of a new animal model of depression, Biol. Psychiatry 21:49–58.
Overstreet, D. H., and Russell, R. W., 1982, Selective breeding for diisopropyl fluorophosphate-sensitivity: Behavioural effects of cholinergic agonists and antagonists, Psychopharmacology 78:150–155.
Overstreet, D. H., and Russell, R. W., 1984, Selective breeding for differences in cholinergic function: Sex differences in the genetic regulation of sensitivity to the anticholinesterase, DFP, Behav. Neural Biol. 40:227–238.
Overstreet, D. H., Russell, R. W., Helps, S. C., and Messenger, M., 1979, Selective breeding for sensitivity to the anticholinesterase DFP, Psychopharmacology 65:15–20.
Overstreet, D. H., Driscoll, P., Martin, J. R., and Yamamura, H. I., 1981, Brain muscarinic cholinergic receptor binding in Roman high-and low-avoidance rats, Psychopharmacology 72:143–145.
Overstreet, D. H., Russell, R. W., Crocker, A. D., and Schiller, G. D., 1984, Selective breeding for differences in cholinergic function: Pre-and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP, Brain Res. 294:327–332.
Overstreet, D. H., Booth, R. A., Dana, R., Risen, S. C., and Janowsky, D. S. 1986a, Enhanced elevation of corticosterone following arecoline administration to rats selectively bred for increased cholinergic function, Psychopharmacology 88:129–130.
Overstreet, D. H., Janowsky, D. S., Gillin, J. C., Shiromani, P. J., and Sutin, E. L., 1986b, Stress-induced immobility in rats with cholinergic supersensitivity, Biol. Psychiatry 21:657–664.
Overstreet, D. H., Russell, R. W., Crocker, A. D., Gillin, J. C., and Janowsky, D. S., 1988, Genetic and pharmacological models of cholinergic supersensitivity and affective disorders, Experientia 44:465–472.
Overstreet, D. H., Double, K., and Schiller, G. D., 1989, Antidepressant effects of rolipram in a genetic animal model of depression: Cholinergic supersensitivity and weight gain, Pharmacol. Biochem. Behav. 34:691–696.
Overstreet, D. H., Rezvani, A. H., and Janowsky, D. S., 1990, Increased hypothermic responses to ethanol in rats selectively bred for cholineric supersensitivity, Alcohol Alcoholism 25:59–65.
Pauls, D. L., 1985, Segregation analysis of bipolar and unipolar disorders in the U.S. Amish, In: Fourth World Congress in Biological Psychiatry, Philadelphia.
Pauly, J. R., Ullman, E. A., and Collins, A. C., 1988, Adrenocortical hormone regulation of nicotine sensitivity in mice, Physiol. Behav. 44:109–116.
Pauly, J. R., Ullman, E. A., and Collins, A. C., 1990, Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse, Pharmacol. Biochem. Behav. 35:171–179.
Pedersen, N., 1981, Twin similarity for usage of common drugs, in: Twin Research 3: Epidemiological and Clinical Studies (L. Gedda, P. Parisi, and W. E. Nance, eds.), Alan R. Liss, New York, pp. 53–59.
Petersen, D. R., Norris, K. J., and Thompson, J. T., 1984, A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice, Drug Metab. Dispos. 12:725–731.
Pomerleau, C. S., Pomerleau, O. F., and Majchrzak, M. J., 1987, Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level, Psychopharmacology 91:391–393.
Raaschou-Nielson, E., 1960, Smoking habits in twins, Dan. Med. Bull. 7(3):82–88.
Roderick, T. H., 1960, Selection for cholinesterase activity in the cerebral cortex of the rat, Genetics 45:1123–1140.
Rosecrans, J. A., and Schechter, M. D., 1972, Brain area nicotine levels in male and female rats of two strains, Arch. Int. Pharmacodyn. 196:46–54.
Russell, R. W., Overstreet, D. H., Messenger, M., and Helps, S. C., 1982, Selective breeding for sensitivity to DFP: Generalization of effects beyond criterion variables, Pharmacol. Biochem. Behav. 17:885–891.
Schlatter, J., and Battig, K., 1979, Differential effects of nicotine and amphetamine on locomotor activity and maze exploration in two rat lines, Psychopharmacology 64:155–161.
Sharp, B. M., and Beyer, B. S., 1986, Rapid desensitization of the acute stimulatory effects of nicotine on the rat plasma adrenocorticotropin and prolactin, J. Pharmacol. Exp. Ther. 238:486–491.
Shields, J., 1962, Monozygotic Twins, Oxford University Press, London, pp. 121–124.
Shiffman, S., 1989, Tobacco “chippers”—individual differences in tobacco dependence, Psychopharmacology 97:539–547.
Sihotang, K., and Overstreet, D. H., 1983, Studies of a possible relationship of brain proteins to changes in behavioral sensitivity to DFP, Life Sci. 32:413–420.
Smolen, A., Smolen, T. N., Wehner, J. M., and Collins, A. C., 1985, Genetically determined differences in acute responses to diisopropylfluorophosphate, Pharmacol. Biochem. Behav. 22:623–630.
Smolen, A., Smolen, T. N., Oh, E. I., and Collins, A. C., 1986, A strain comparison of physiological and locomotor responses of mice to diisopropylfluorophosphate, Pharmacol. Biochem. Behav. 24:1077–1082.
Stolerman, I. P., Goldfarb, T., Fink, R., and Jarvik, M. E., 1973, Influencing cigarette smoking with nicotine antagonists, Psychopharmacologia 28:247–259.
Tepper, J. M., Wilson, J. R., and Schlesinger, K., 1979, Relations between nicotine-induced convulsive behavior and blood and brain levels of nicotine as a function of sex and age in two inbred strains of mice, Pharmacol. Biochem. Behav. 10:349–353.
Todd, G. F., and Mason, J. I., 1959, Concordance of smoking habits in monozygotic and dizygotic twins, Heredity 13:417–444.
van Abeelen, J. H. F., and Strijbosch, H., 1969, Genotype-dependent effects of scopolamine and eserine on exploratory behaviour in mice, Psychopharmacologia (Berl.) 16:81–88.
van Abeelen, J. H. F., Smits, A. J. M., and Raaijmakers, W. G. M., 1971, Central location of a genotype-dependent cholinergic mechanism controlling exploratory behaviour in mice, Psychopharmacologia (Berl.) 19:324–328.
van Abeelen, J. H. F., Gilissen, L., Hanssen, T., and Lenders, A., 1972, Effects of intrahippo-campal injections with methylscopolamine and neostigmine upon exploratory behaviour in two inbred mouse strains, Psychopharmacologia (Berl.) 24:470–475.
Wehner, J. M., Murphy-Erdosh, C., Smolen, A., and Smolen, T. N., 1987, Genetic variation in paraoxonase activity and sensitivity to diisopropylphosphofluoridate in inbred mice, Pharmacol. Biochem. Behav. 28:317–320.
Weissman, M. M., Gershon, E. S., Kidd, K. K., Prusoff, B. A., Leckman, J. F., Dibble, E., Hamovit, J., Thompson, W. D., Pauls, D. L., and Guroff, J. J., 1984, Psychiatric disorders in the relatives of probands with affective disorders, Arch. Gen. Psychiatry 41:13–21.
Wenger, G. R., 1989, The role of control activity levels in the reported strain differences to the behavioral effects of drugs in mice, Pharmacol. Biochem. Behav. 32:241–247.
West, R. J., and Russell, M. A. H., 1985, Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms, Psychopharmacology 87:334–336.
West, R. J., and Russell, M. A. H., 1988, Loss of acute nicotine tolerance and severity of cigarette withdrawal, Psychopharmacology 94:563–565.
West, R. J., Hajek, P., and Belcher, M., 1986, Which smokers report most relief from craving when using nicotine chewing gum? Psychopharmacology 89:189–191.
Winokur, G., and Clayton, P. J., 1967, Family history studies, I. Two types of affective disorders separated according to genetic and clinical factors, in: Recent Advances in Biological Psychiatry (J. Wortis, ed.) Plenum Press, New York, Vol. IX, pp. 35–50.
Young, A. P., and Sigman, D. S., 1981, Allosteric effects of volatile anesthetics on the membrane-bound acetylcholine receptor. II. Alteration of α-bungarotoxin binding kinetics, Mol. Pharmacol. 20:506–510.
Zacny, J. P., and Stitzer, M. L., 1988, Cigarette brand-switching: Effects on smoke exposure and smoking behavior, J. Pharmacol. Exp. Ther. 246:619–627.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Collins, A.C., Marks, M.J. (1991). Genetic Studies of Nicotinic and Muscarinic Agents. In: Crabbe, J.C., Harris, R.A. (eds) The Genetic Basis of Alcohol and Drug Actions. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2067-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2067-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2069-0
Online ISBN: 978-1-4899-2067-6
eBook Packages: Springer Book Archive